Llwytho...
Assessing quality of life of idiopathic pulmonary fibrosis patients: the INSTAGE study
The addition of sildenafil to nintedanib treatment does not improve outcomes to a greater extent than monotherapy with nintedanib, and it is not recommended for IPF subjects http://ow.ly/Gaq530o9kEg
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Breathe (Sheff) |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
European Respiratory Society
2019
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6544796/ https://ncbi.nlm.nih.gov/pubmed/31191729 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/20734735.0016-2019 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|